Perigon Wealth Management, LLC Editas Medicine, Inc. Transaction History

Perigon Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $21,125 - $48,188	-532 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$27.07 - $84.35 $14,401 - $44,874	532 New	532 $37,000
Q3 2018 Nov 13, 2018	SELL	$27.65 - $38.39 $179,061 - $248,613	-6,476 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$31.4 - $41.01 $203,346 - $265,580	6,476 New	6,476 $232,000
Q4 2017 Feb 14, 2018	SELL	$21.89 - $31.34 $108,837 - $155,822	-4,972 Closed	0 $0
Q3 2017 Dec 05, 2017	BUY	$15.81 - $24.01 $78,607 - $119,377	4,972	4,972 $119,000

240

56.5M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $85.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.